Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 148 entries
View as:

Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos

Phase: N/A Priority: Normal
NCT ID: NCT01719068 Org: User:
Start: 10/31/12 End: 12/31/14 Due: 12/31/15

Do Skin Markings Reflect the Location of the Surgical Cavity During Daily Radiotherapy Treatment?

Phase: N/A Priority: Normal
NCT ID: NCT00578747 Org: User:
Start: 01/31/08 End: 12/31/10 Due: 12/31/11

Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype Early Stage Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04705649 Org: User:
Start: 07/14/20 End: 06/22/23 Due: 06/22/24

The Bowel Research Collaborative Data Tracking System Implementation Study

Phase: N/A Priority: Normal
NCT ID: NCT00728975 Org: User:
Start: 06/30/08 End: 02/28/10 Due: 02/28/11

Phase II Study of Perindopril and Regorafenib in mCRC

Phase: N/A Priority: Normal
NCT ID: NCT02651415 Org: User:
Start: 08/31/16 End: 11/07/18 Due: 11/07/19

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT06208735 Org: User:
Start: 01/02/25 End: 08/01/27 Due: 08/01/28

Sequencing Abiraterone and Enzalutamide in mCRPC

Phase: N/A Priority: Normal
NCT ID: NCT02125357 Org: User:
Start: 09/30/14 End: 02/04/20 Due: 02/04/21

Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06200974 Org: User:
Start: 02/01/24 End: 02/01/38 Due: 02/01/39

Long Term Outcomes of Breast Intensity-Modulated Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01537406 Org: User:
Start: 03/31/12 End: 05/31/13 Due: 05/31/14

Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT03769103 Org: User:
Start: 03/19/19 End: 04/30/25 Due: 04/30/26

DOTATATE PET for Meningioma Radiation Planning

Phase: N/A Priority: Normal
NCT ID: NCT06937268 Org: User:
Start: 06/30/25 End: 12/31/27 Due: 12/31/28

Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol

Phase: N/A Priority: Normal
NCT ID: NCT00569712 Org: User:
Start: 01/31/07 End: 12/31/08 Due: 12/31/09

A Randomized Trial of Letters From Family Physicians to Encourage Screening Mammography in Overdue Women

Phase: N/A Priority: Normal
NCT ID: NCT02660788 Org: User:
Start: 02/28/13 End: 12/31/15 Due: 12/31/16

Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate

Phase: N/A Priority: Normal
NCT ID: NCT01174017 Org: User:
Start: 09/30/10 End: 12/31/11 Due: 12/31/12

Acupuncture in Palliative Cancer Care

Phase: N/A Priority: Normal
NCT ID: NCT00302185 Org: User:
Start: 06/30/07 End: 03/31/08 Due: 03/31/09

Monitoring and Managing Glucose Levels in People With Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05132244 Org: User:
Start: 04/16/24 End: 04/30/27 Due: 04/30/28

177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs

Phase: N/A Priority: Normal
NCT ID: NCT04915144 Org: User:
Start: 01/15/23 End: 12/31/31 Due: 12/31/32

Biomarker - Panitumumab Response With KRAS Wild Type MCC

Phase: N/A Priority: Normal
NCT ID: NCT00853931 Org: User:
Start: 10/31/09 End: 09/30/15 Due: 09/30/16

Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06574620 Org: User:
Start: 04/30/25 End: 12/31/31 Due: 12/31/32

(Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02627703 Org: User:
Start: 05/31/10 End: - Due: -

Utilization of Genomic Information to Augment Chemotherapy Decision-making for People With Incurable Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01802905 Org: User:
Start: 06/30/12 End: 02/28/15 Due: 02/28/16

ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia

Phase: N/A Priority: Normal
NCT ID: NCT00522197 Org: User:
Start: 09/30/02 End: 11/30/08 Due: 11/30/09

Efficacy and Safety of Omega 3 Fatty Acid Supplements on Heavy Smokers

Phase: N/A Priority: Normal
NCT ID: NCT03936621 Org: User:
Start: 06/01/19 End: 06/01/22 Due: 06/01/23

Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia in Patients With An Abnormal Pap Smear

Phase: N/A Priority: Normal
NCT ID: NCT00610662 Org: User:
Start: 12/31/10 End: 09/30/14 Due: 09/30/15

Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging

Phase: N/A Priority: Normal
NCT ID: NCT04017104 Org: User:
Start: 11/01/19 End: 08/01/24 Due: 08/01/25